Web Results

law.justia.com/cases/delaware/superior-court/2017/n16c-12-231-pra.html

Machala v. Boehringer Ingelheim Pharmaceuticals, Inc., et al.

law.justia.com/cases/federal/district-courts/pennsylvania/pawdce/2:2017cv01153/240814/20

Feb 15, 2018 ... BELL v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al, No. 2: 2017cv01153 - Document 20 (W.D. Pa. 2018) case opinion from ...

www.law360.com/cases/59820bc59c43e06ea0000001

Parties, docket activity and news coverage of federal case AbbVie Inc. et al v. Boehringer Ingelheim International GMBH et al, case number 1:17-cv-01065, from ... for modulating protein glycosylation profiles of recombinant protein therapeutics ...

www.ftc.gov/enforcement/cases-proceedings/091-0023/boehringer-ingelheim-pharmaceuticals-inc

Aug 21, 2017 ... Federal Trade Commission v. Boehringer Ingelheim Pharmaceuticals, Inc. (D.C. Cir.), Final Opening Brief of the Federal Trade Commission, ...

www.cadc.uscourts.gov/internet/opinions.nsf/A81BAEEA3D756416852582B100518ADF/$file/16-5356.pdf

Jun 19, 2018 ... Boehringer Ingelheim Pharmaceuticals, Inc. Warren D. ... alleged infringer, rather than the other way around.” FTC v. Actavis, Inc., 570 U.S. 136, 141 (2013). .... All of those communications are protected by the attorney-client ...